DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) announced the presentation of a poster at the 61st Annual Meeting of the American College of Neuropsychopharmacology, being held December 4-7, 2022 in Phoenix, Ariz.
Poster Presentation Details
Title: An Open-Label Tolerability and Efficacy Study of ZYN002 (Cannabidiol) Administered as a Transdermal Gel to Children and Adolescents with 22q11.2 Deletion Syndrome (INSPIRE)
Date available: Available online beginning December 5, 2022, for the entirety of the conference
Live presentation: In-person presentation, Poster Session III, December 7, 2022, 5:30 p.m. – 7:30 p.m. MST
Location: JW Marriott Desert Ridge Resort and Spa, Phoenix, Ariz.
A copy of the poster will be made available on the Zynerba corporate website following the presentation at www.zynerba.com/publications.
Thanks for visiting! Looking for some Chester County pride? We got you covered! Shop our MyChesCo store and show your love for Chester County, Pennsylvania. We got shirts, hats, and more – all with a unique ChesCo flair. Plus, proceeds from each purchase helps support our mission of bringing reliable information and resources to the people of Chester County.